| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMA/CHMP/496931/2011 (24.6.11) |
| Publication Date | 24/06/2011 |
| Content Type | News |
|
The European Medicines Agency (EMA), on 24 June 2011, recommended the approval of Eurartesim, from Sigma-tau Industrie Farmaceutiche Riunite S.p.A., for the treatment of uncomplicated Plasmodium falciparum malaria in adults, children and infants aged 6 months or over and weighing 5 kg or more. |
|
| Source Link | Link to Main Source http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/06/news_detail_001289.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |
